There are 10 emerging healthcare trends that will impact managed care pharmacy organizations over the next 5 years as the United States healthcare system places more emphasis on affordability, population health, and patient satisfaction and quality of care, according to a new report from the Academy of Managed Care Pharmacy.
There are 10 emerging healthcare trends that will impact managed care pharmacy organizations over the next 5 years as the United States healthcare system places more emphasis on affordability, population health, and patient satisfaction and quality of care, according to a new report from the Academy of Managed Care Pharmacy (AMCP).
The newly released AMCP Foundation report, “Ahead of the Curve: Top 10 Emerging Health Care Trends — Implications for Patients, Providers, Payers and Pharmaceuticals,” outlines the 10 trends and their effect on the health system.
The purpose of the report, according to Edith A. Rosato, RPh, IOM, chairman of the AMCP Foundation Board of Trustees and chief executive officer of AMCP, is to assess major changes occurring in the healthcare system over the next 5 years and identify key strategies to harness the 10 trends and achieve the Triple Aim of health reform.
“To prepare for these emerging healthcare trends, various stakeholders will need to gener­ate novel solutions to improve patient metrics and tracking, enhance patient engagement and find approaches that can drive accountability, curtail costs, and incentivize quality,” according to the report.
The 10 trends in the report are as follows:
“In this fast-paced environment, it is critical to understand the shifting landscape so that organizations can anticipate changes and prioritize actions,” David Moules, vice president of Pfizer, Inc, US Payer & Channel Access, said in a statement. “The results of ‘Ahead of the Curve’ validates the biopharmaceutical industry’s efforts to discover, develop and bring to market medicines deemed to be of value to the healthcare system including those that are responsible for paying for the medicines.”
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Homelessness Compounds Hospital Stay Challenges: Study Reveals Prolonged Discharge Struggles
March 28th 2024In this investigation, outcomes of interest were morbidity rate and length of hospital stay or a traumatic injury among a homeless population, and whether age and/or injury severity had an influence on that relationship—with implications for improving the discharge process for these patients.
Read More
FDA Approves Vadadustat for Anemia in Patients With CKD Undergoing Dialysis
March 28th 2024The FDA approved vadadustat (Vafseo), an oral medication, to treat anemia in adult patients with chronic kidney disease (CKD) on dialysis for at least 3 months. This fills a need for a new treatment option as anemia is common in these patients and can significantly impact their quality of life.
Read More